<DOC>
	<DOCNO>NCT00116727</DOCNO>
	<brief_summary>To systematically collect document use pattern , effectiveness safety DMARD treatments currently use management rheumatoid arthritis . The primary purpose study estimate incidence serious adverse experience adverse experience interest patient rheumatoid arthritis ( RA ) treat ENBREL® .</brief_summary>
	<brief_title>Rheumatoid Arthritis DMARD Intervention UtilizationStudy</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Fulfillment 1987 American Rheumatism Association criterion RA Currently require addition ENBREL® therapy ( take alone addition current DMARD therapy ) Currently previously enrol RADIUS 1 Currently enrol clinical trial treatment patient visit impose protocol Active infection Known allergy ENBREL® component Current treatment ENBREL® Patients previously demonstrate intolerant refractory ENBREL® therapy Nursing pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>DMARD</keyword>
</DOC>